MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejphar.2024.177095

Медицинская библиотека · European journal of pharmacology · 2024

The power of three: Retatrutide's role in modern obesity and diabetes therapy.

Abdul-Rahman Toufik, Roy Poulami, Ahmed Fatma Kamal, Mueller-Gomez Jann Ludwig, Sarkar Sarmistha, Garg Neil, Femi-Lawal Victor Oluwafemi, Wireko Andrew Awuah, Thaalibi Hala Ibrahim, Hashmi Muhammad Usman, Dzebu Andrew Sefenu, Banimusa Sewar Basheer, Sood Aayushi

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The increasing prevalence of obesity and type 2 diabetes mellitus has resulted in a significant challenge to public health throughout the globe. It required the development of novel therapeutic approaches. Retatrutide is a groundbreaking triple agonist that targets glucagon receptors, gastric inhibitory polypeptide, and glucagon-like peptide-1. Retatrutide's complex mechanism of action involves a synergistic interaction among these receptors, resulting in increased insulin secretion, improved glucose homeostasis, and refined appetite modulation. Clinical trials in phases 1 to 3 have demonstrated significant efficacy, highlighted by significant reductions in body weight and favorable glycemic control outcomes. Additionally, retatrutide shows promise in mitigating cardiovascular risk factors and addressing metabolic dysfunction-associated steatotic liver disease. However, careful attention is required to delineate its long-term safety profile, explore its potential in special populations, unravel its adjunctive therapeutic roles, and elucidate its mechanisms in pediatric cohorts. As a transformative therapeutic modality, retatrutide represents a beacon of hope, signifying transformative changes in the management landscape of obesity and type 2 diabetes mellitus (T2DM), and warranting continued exploration and refinement in clinical practice. This narrative review examines the therapeutic potential of retatrutide in the management of obesity and T2DM.

Для цитирования: Abdul-Rahman Toufik, Roy Poulami, Ahmed Fatma Kamal, Mueller-Gomez Jann Ludwig, Sarkar Sarmistha, Garg Neil, Femi-Lawal Victor Oluwafemi, Wireko Andrew Awuah, Thaalibi Hala Ibrahim, Hashmi Muhammad Usman, Dzebu Andrew Sefenu, Banimusa Sewar Basheer, Sood Aayushi. The power of three: Retatrutide's role in modern obesity and diabetes therapy.. European journal of pharmacology. 2024. DOI: 10.1016/j.ejphar.2024.177095.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.